Eli M. Roth
Impact in
- Surgery top 1%
- Lipoproteins and Cardiovascular Health
- Coronary Interventions and Diagnostics
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
- Surgery 47
- Lipoproteins and Cardiovascular Health 41
- Coronary Interventions and Diagnostics 6
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 12
- Co-authors
- James M. McKenney (8 shared papers)Evan A. Stein (8 shared papers)Corinne Hanotin (9 shared papers)Gaëlle Asset (2 shared papers)Maria Laura Monsalvo (4 shared papers)Scott M. Wasserman (5 shared papers)Dirk Blom (4 shared papers)Robert C. Scott (4 shared papers)
- Journals
- Journal of clinical lipidology (8 papers)Atherosclerosis (5 papers)Journal of the American College of Cardiology (5 papers)American Heart Journal (3 papers)Clinical Therapeutics (2 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Eli M. Roth
58 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Surgery 2.1k
- Endocrinology, Diabetes and Metabolism 587
- Economics and Econometrics 781
- Cardiology and Cardiovascular Medicine 586
- Cancer Research 315
Countries citing papers authored by Eli M. Roth
This map shows the geographic impact of Eli M. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli M. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli M. Roth more than expected).
Fields of papers citing papers by Eli M. Roth
This network shows the impact of papers produced by Eli M. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli M. Roth. The network helps show where Eli M. Roth may publish in the future.
Co-authors
The 25 scholars most cited alongside Eli M. Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia Hit paper breakdown → | 2014 | 553 |
| 2 | Atorvastatin with or without an Antibody to PCSK9 in Primary Hypercholesterolemia Hit paper breakdown → | 2012 | 383 |
| 3 | 2014 | 211 | |
| 4 | 2014 | 167 | |
| 5 | 1999 | 103 | |
| 6 | 2016 | 100 | |
| 7 | 2001 | 95 | |
| 8 | 2013 | 83 | |
| 9 | 2010 | 83 | |
| 10 | 2015 | 77 | |
| 11 | 2007 | 67 | |
| 12 | 2009 | 57 | |
| 13 | 2015 | 57 | |
| 14 | 2015 | 53 | |
| 15 | 2016 | 48 | |
| 16 | 2014 | 47 | |
| 17 | 2015 | 45 | |
| 18 | 2016 | 39 | |
| 19 | 2014 | 38 | |
| 20 | 2010 | 31 |
About Eli M. Roth
Eli M. Roth is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Economics and Econometrics and Cancer Research, having authored 60 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (41 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Cancer, Lipids, and Metabolism (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Pharmaceutical Economics and Policy (8 papers), Lipid metabolism and disorders (6 papers) and Coronary Interventions and Diagnostics (6 papers). The work is most often cited by research in Surgery (2.1k citations), Endocrinology, Diabetes and Metabolism (587 citations), Economics and Econometrics (781 citations), Cardiology and Cardiovascular Medicine (586 citations) and Cancer Research (315 citations). Eli M. Roth has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include James M. McKenney, Evan A. Stein, Corinne Hanotin, Gaëlle Asset, Maria Laura Monsalvo, Scott M. Wasserman, Dirk Blom, Robert C. Scott, Christie M. Ballantyne and Michael J. Koren. Their work appears in journals such as Journal of clinical lipidology, Atherosclerosis, Journal of the American College of Cardiology, American Heart Journal and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.